Prof. TÜRKKAN EVRENSEL

Publication Network

Articles 113

1. Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

Majidova N., Arak H., ÖZALP F. R., BAŞ O., ÖZÇELİK KÖKER G., Ozmarasali E. B., et al.

SCIENTIFIC REPORTS , vol.15, no.1, 2025 (SCI-Expanded)

2. Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study

Birsin Z., Nazlı İ., Alkan O., ODABAŞI BÜKÜN H., Günaltılı M., Çerme E., et al.

Journal of Clinical Medicine , vol.14, no.20, 2025 (SCI-Expanded)

3. Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data

Şahin Çelik B., Geçgel A., Özkan O., Majidova N., ERKAN ÖZMARASALI B., Ağdaş G., et al.

Journal of Clinical Medicine , vol.14, no.20, 2025 (SCI-Expanded)

4. Managing Bone Metastases with Denosumab: Real-World Data and Critical Monitoring Points in Breast, Lung, and Prostate Cancers

Oyucu Orhan S., Orhan B., ESENBUĞA Ş., Sali S., Caner B., Ocak B., et al.

Medicina (Lithuania) , vol.61, no.9, 2025 (SCI-Expanded)

5. Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study

Birsin Z., ODABAŞI BÜKÜN H., Nazlı İ., Alkan O., Günaltılı M., Çerme E., et al.

Medicina (Lithuania) , vol.61, no.9, 2025 (SCI-Expanded)

6. Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast

Sali S., SALİ M., Caner B., Ocak B., ÇOBAN E., COŞKUN A., et al.

Oncologist , vol.30, no.8, 2025 (SCI-Expanded)

7. Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis

Şahin Çelik B., Peker P., ÖZÇELİK E. E., Kuzu Ö. F., Gökmen E., Başaran G., et al.

Cancers , vol.17, no.14, 2025 (SCI-Expanded)

8. Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis

Coskun A., ŞAHİN A. B., KABUL S., Celik M. A., SALİ M., ÖZÇELİK E. E., et al.

Current Oncology , vol.32, no.7, 2025 (SCI-Expanded)

9. Prediction of Cardiac Arrhythmias in Cancer Patients Treated with Immune Checkpoint Inhibitors Using Electrocardiogram

Coskun A., Celebi Coskun E., ŞAHİN A. B., Levent F., Coban E., Koca F., et al.

Diagnostics , vol.15, no.10, 2025 (SCI-Expanded)

10. Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Ocak B., ŞAHİN A. B., Ertürk I., Korkmaz M., Erdem D., Cakıroglu U., et al.

Current Oncology , vol.31, no.9, pp.5195-5205, 2024 (SCI-Expanded)

11. Retrospective Analysis of Patients Diagnosed with Primary Gastric NonHodgkin’s Lymphoma and Potential Prognostic Markers

ORHAN B., ORHAN S. O., DELİGÖNÜL A., ÇUBUKÇU E., EVRENSEL T., ALİ R., et al.

Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi , vol.38, no.2, pp.120-126, 2024 (Peer-Reviewed Journal)

12. Retrospektif analysis of patients diagnosed with primary gastric NonHodgkin's Lymphoma and Potential prognostic markers

ORHAN B., OYUCU ORHAN S., Saydam N. H., CANER B., ÖZKOCAMAN V., ERSAL T., et al.

Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi , vol.38, no.2, 2024 (Peer-Reviewed Journal)

13. Investigation of the Relationship Between Tumor Microenvironment and Prognostic Parameters in Invasive Breast Carcinomas of No Special Type: A Retrospective Analysis

ÖZŞEN M., Tolunay S., ŞENOL K., DELİGÖNÜL A., GÖKGÖZ M. Ş., EVRENSEL T.

Turk Patoloji Dergisi , vol.40, no.3, pp.170-180, 2024 (ESCI)

14. Histopathological Features Predicting Neuroendocrine Morphology in Primary Breast Tumors: A Retrospective Analysis

ÖZŞEN M., ŞENOL K., TOLUNAY Ş., GÖKGÖZ M. Ş., EVRENSEL T.

European Journal of Breast Health , vol.20, no.2, pp.110-116, 2024 (ESCI)

15. Left ventricular global longitudinal strain in patients treated with immune checkpoint inhibitors

Coskun E. C., COŞKUN A., ŞAHİN A. B., Levent F., ÇOBAN E., Koca F., et al.

FRONTIERS IN ONCOLOGY , vol.14, 2024 (SCI-Expanded)

16. Immunotherapy experience in sinonasal NUT midline carcinoma, case report

CANER B., Orhan S. O., DELİGÖNÜL A., EVRENSEL T.

Journal of Cancer Research and Therapeutics , vol.20, no.1, pp.479-481, 2024 (SCI-Expanded)

17. The effect of two different types of music played to cancer patients during chemotherapy on anxiety, nausea, and satisfaction levels

Erbay Dallı Ö., Akça Doğan D., Pehlivan S., Yıldırım Y., Evrensel T.

SUPPORTIVE CARE IN CANCER , vol.31, no.12, 2023 (SCI-Expanded, Scopus) Sustainable Development

18. Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment

ŞAHİN A. B., Caner B., Ocak B., Gulmez A., HAMİTOĞLU B., ÇUBUKÇU E., et al.

ONCOLOGY LETTERS , vol.26, no.6, 2023 (SCI-Expanded) Sustainable Development

19. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Unal C., Azizy A., Karabulut S., Tastekin D., AKYILDIZ A., YAŞAR S., et al.

ONCOLOGIST , vol.28, pp.875-884, 2023 (SCI-Expanded)

20. Prognostic factors in atypical carcinoid tumors

Şahin A. B., cubukcu e., deligonul a., Ocak B., MELEK H., erkan B., et al.

The European Research Journal , vol.9, no.5, pp.1194-1200, 2023 (Peer-Reviewed Journal)

21. The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy

Karacan Y., YILDIZ H., EVRENSEL T., HAZNEDAROĞLU İ. C.

SUPPORTIVE CARE IN CANCER , vol.31, no.7, 2023 (SCI-Expanded)

22. Glioblastoma multiforme tanılı olgularımızda sağkalım ve prognostik faktörlerin değerlendirilmesi: retrospektif çalışma

Sarıhan S., Aslan G. G., Evrensel T., Kocaeli H.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.49, no.1, pp.63-70, 2023 (Peer-Reviewed Journal)

23. Retrospective Comparison of the Efficacy of Therapeutic Agents in Metastatic Soft-Tissue Sarcomas

CANER B., Ocak B., Sahin A. B., SALİ S., Coban E., DELİGÖNÜL A., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.38, pp.238-245, 2023 (ESCI)

24. Radical Surgery With a Multidisciplinary Approach In a Case of Radiation Induced Rhabdomyosarcoma of Breast Invading The Chest Wall, Lung And Heart

ŞENOL K., POLATKAN S. A. V., ACAR İ. Z., ÇEÇEN S., BAYRAM A. S., ÖZŞEN M., et al.

Cappadocia University , vol.1, no.1, pp.25-30, 2022 (Peer-Reviewed Journal)

25. Platin-based chemotherapy does not improve survival in patients with non-metastatic resected typical carcinoid tumors

ŞAHİN A. B., MELEK H., OCAK B., OYUCU ORHAN S., ERKAN B., CANER B., et al.

MOLECULAR AND CLINICAL ONCOLOGY , vol.17, no.4, 2022 (ESCI)

26. Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey

ÖZET A., DANE F., Aykan N. F., YALÇIN Ş., EVRENSEL T., ÖZKAN M., et al.

FUTURE ONCOLOGY , vol.18, no.29, pp.3267-3276, 2022 (SCI-Expanded) Sustainable Development

27. The Effect of Treatment Options on Survival in Patients with Metastatic Endometrioid Endometrial Carcinoma

Ocak B., Sahın A. B., Abakay C. D., Sali S., Dakiki B., İşlek G., et al.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.48, no.1, pp.37-41, 2022 (Peer-Reviewed Journal)

28. Radiotherapy could increase the efficacy of immunotherapy in non-small cell lung cancer

Ocak B., Sarıhan S., Şahin A. B., Dakiki B., Caner B., Gülsen K., et al.

TURKISH JOURNAL OF INTERNAL MEDICINE , vol.4, no.1, pp.71-80, 2022 (Peer-Reviewed Journal)

29. Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma

Sahin A. B., Ocak B., Abakay C., Çubukçu E., Deligönül A., Caner B., et al.

European Review for Medical and Pharmacological Sciences , vol.26, no.23, pp.8959-8968, 2022 (SCI-Expanded) Sustainable Development

30. Why do some patients with stage 1A and 1B endometrial endometrioid carcinoma experience recurrence? A retrospective study in search of prognostic factors.

Ocak B., Sahin A. B., Oz Atalay F., Ozsen M., Dakiki B., Ture S., et al.

Ginekologia polska , vol.93, pp.112-120, 2022 (SCI-Expanded)

31. Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , vol.233, no.6, pp.742-752, 2021 (SCI-Expanded) Sustainable Development

32. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy

Şahin A. B., Cubukcu E., Ocak B., Deligonul A., Oyucu Orhan S., Tolunay S., et al.

SCIENTIFIC REPORTS , no.1, 2021 (SCI-Expanded)

33. DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer.

Deligonul A., Aksoy S., Tezcan G., Tunca B., Kanat O., Cubukcu E., et al.

Genetic testing and molecular biomarkers , vol.25, no.4, pp.276-283, 2021 (SCI-Expanded, Scopus) Sustainable Development

34. Osteosarcoma of rib treated with regorafenib: a case report

SAKAR O., UÇARYILMAZ C., ŞAHİN A. B., EVRENSEL T., GEBİTEKİN C.

UNIVERSOS JURÍDICOS , vol.3, pp.62-64, 2021 (Peer-Reviewed Journal)

35. The Importance of Platinum Sensitivity in Metastatic Malignant Pleural Mesothelioma Patients

OCAK B., ŞAHİN A. B., DAKİKİ B., ODMAN H. U., sağlam n. h., OYUCU ORHAN S., et al.

Eurasian Journal of Medical Investigation , vol.5, pp.89-94, 2021 (Peer-Reviewed Journal)

36. The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer.

Ocak B., Atalay F. Ö., Sahin A. B., Ozsen M., Dakiki B., Türe S., et al.

Bosnian journal of basic medical sciences , vol.21, no.5, pp.549-554, 2021 (SCI-Expanded)

37. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

Bahçeci A., Paydaş S., Ak N., Ferhatoğlu F., Saip P. M., Seydaoğlu G., et al.

CANCER INVESTIGATION , vol.39, no.6-7, pp.473-481, 2021 (SCI-Expanded) Sustainable Development

38. Prognostic Significance of Microsatellite Instability in Turkish Patients with Stage II and III Colorectal Cancer

DELİGÖNÜL A., AVCI N., KURT M., ÖZEMRİ SAĞ Ş., IŞIK Ö., HAFIZOĞLU M., et al.

Eurasian Journal of Medical Investigation , vol.5, no.1, pp.62-66, 2021 (Peer-Reviewed Journal) Sustainable Development

39. Tolvaptan in the Treatment of the Syndrome of Inappropriate Anti-Diuretic Hormone in Cancer Patients

OCAK B., ŞAHİN A. B., DAKİKİ B., CANER B., ERTAŞ H., OYUCU ORHAN S., et al.

Eurasian Journal of Medical Investigation , vol.4, no.4, pp.490-494, 2020 (Peer-Reviewed Journal) Sustainable Development

40. Türk kadınlarında MDR1 (ABCB1) geni C3435T, C1236T, G2677T/A, A2956G polimorfizmleri ile meme kanseri riski arasındaki ilişki

MUTLU İÇDUYGU F., ŞAMLI H., EVRENSEL T., ÖZGÖZ A., HEKİMLER ÖZTÜRK K., CANHOROZ M., et al.

Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi , vol.27, no.3, pp.345-352, 2020 (Peer-Reviewed Journal)

41. Malign Peritoneal Mesotelyoma Hastalarının Retrospektif Değerlendirilmesi

OCAK B., ŞAHİN A. B., DAKİKİ B., odman h. u., DELİGÖNÜL A., ÇUBUKÇU E., et al.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.46, no.1, pp.25-29, 2020 (Peer-Reviewed Journal)

42. Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients

ÇEÇENER G., Takanlou L. S., Takanlou M. S., EGELİ Ü., Eskiler G. G., AKSOY S., et al.

CANCER GENETICS , vol.240, pp.23-32, 2020 (SCI-Expanded, Scopus) Sustainable Development

43. The benefit of surgery on survival for patients with stage 1 and 2 malignant pleural mesothelioma

OCAK B., ŞAHİN A. B., DAKİKİ B., ODMAN H. U., OYUCU ORHAN S., DELİGÖNÜL A., et al.

Dicle Tıp Dergisi , 2020 (Peer-Reviewed Journal)

44. BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients

ÇEÇENER G., EGELİ Ü., TUNCA B., ERTÜRK BAKIR E., AKSOY S., Gokgoz S., et al.

CANCER INVESTIGATION , vol.32, no.8, pp.375-387, 2014 (SCI-Expanded, Scopus) Sustainable Development

45. Cisplatin Plus Etoposide in the Adjuvant Treatment of Patients with Non Small Cell Lung Cancer

Cubukcu E., Canhoroz M., Olmez O. F., Kanat O., Kurt E., Erol M., et al.

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , vol.5, no.5, pp.414-416, 2014 (ESCI)

46. Molecular Markers for Patients with Thymic Malignancies: not Feasible at Present?

Avci N., ÇEÇENER G., DELİGÖNÜL A., ERTÜRK BAKIR E., TUNCA B., EGELİ Ü., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.8, pp.3457-3460, 2014 (SCI-Expanded) Sustainable Development

47. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer

Cubukcu E., Kanat O., Olmez O. F., Kabul S., Canhoroz M., Avci N., et al.

JOURNAL OF BUON , vol.18, no.2, pp.359-365, 2013 (SCI-Expanded) Sustainable Development

48. Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer

Bayrak M., Olmez O. F., Kurt E., ÇUBUKÇU E., EVRENSEL T., Kanat O., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY , vol.15, no.4, pp.307-312, 2013 (SCI-Expanded) Sustainable Development

49. Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients

TUNCA B., Tezcan G., ÇEÇENER G., EGELİ Ü., Zorluoglu A., Yilmazlar T., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.139, no.4, pp.691-702, 2013 (SCI-Expanded, Scopus) Sustainable Development

50. Prognostic Significance of Human Epidermal Receptor (HER)-3 Immunohistochemical Expression in Patients with Metastatic Breast Cancer

Olmez O. F., EVRENSEL T., ÇUBUKÇU E., UĞRAŞ N., Avci N., Canhoroz M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.7, pp.4115-4119, 2013 (SCI-Expanded) Sustainable Development

51. Küçük Hücreli Akciğer Kanserli Bir Hastada Ektopik ACTH Sendromu: Olgu Sunumu

AVCI N., KURT E., KAZAK E., ALKIŞ N., ÇUBUKÇU E., ÖLMEZ Ö. F., et al.

Uludağ Üniversitesi hakemli dergilerinde yayımlanan , 2013 (Peer-Reviewed Journal) Sustainable Development

52. A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.

KURT M., Cubukcu E., Karabulut B., Olmez O. F., KURT M., Avci N., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.18, no.1, pp.147-53, 2013 (SCI-Expanded) Sustainable Development

53. OCTOGENARIANS: LOOKING CLOSER TO A NEW GROUP OF CANCER PATIENTS

Canhoroz M., Kanat O., EVRENSEL T.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , vol.16, no.1, pp.117-118, 2013 (SCI-Expanded) Sustainable Development

54. The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis

Bozcuk H., Abalı H., Çoşkun Ş., Aydıner A., Çinkaya A., Demirkazık A., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.10, 2012 (SCI-Expanded)

55. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors.

Cubukcu E., Olmez O. F., Avci N., Canhoroz M., Kurt E., Kanat O., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.17, no.3, pp.517-21, 2012 (SCI-Expanded)

56. XRCC1 Gene Polymorphisms and Risk of Lung Cancer in Turkish Patients

Karkucak M., Yakut T., EVRENSEL T., DELİGÖNÜL A., Gulten T., OCAKOĞLU G., et al.

INTERNATIONAL JOURNAL OF HUMAN GENETICS , vol.12, no.2, pp.113-117, 2012 (SCI-Expanded) Sustainable Development

57. CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer

TUNCA B., EGELİ Ü., ÇEÇENER G., TEZCAN G., Gokgoz S., Tasdelen L., et al.

TUMORI JOURNAL , vol.98, no.2, pp.243-251, 2012 (SCI-Expanded, Scopus) Sustainable Development

58. Clinical outcomes of lung metastasectomy in patients with colorectal cancer

Olmez O. F., ÇUBUKÇU E., BAYRAM A. S., Akcali U., EVRENSEL T., GEBİTEKİN C.

WORLD JOURNAL OF GASTROENTEROLOGY , vol.18, no.7, pp.662-665, 2012 (SCI-Expanded) Sustainable Development

59. Pulmonary actinomycosis mimicking metastasis from lung adenocarcinoma.

Olmez O. F., ÇUBUKÇU E., EVRENSEL T., Kanat O., Kurt E., AKYILDIZ E. Ü., et al.

Onkologie , vol.35, no.10, pp.604-6, 2012 (SCI-Expanded) Sustainable Development

60. Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome

ÇUBUKÇU E., Olmez O. F., SARAYDAROĞLU Ö., Akcali U., Kanat O., Kurt E., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY , vol.13, no.11, pp.826-830, 2011 (SCI-Expanded) Sustainable Development

61. Primary small cell carcinoma of the breast: report of seven cases and review of the literature

Kanat O., Kilickap S., Korkmaz T., Oven B. B. U., Canhoroz M., ÇUBUKÇU E., et al.

TUMORI , vol.97, no.4, pp.473-478, 2011 (SCI-Expanded)

62. Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients

Ulukaya E., Karaagac E., ARI F., ORAL A., BALABAN ADIM Ş., Tokullugil A. H., et al.

RADIOLOGY AND ONCOLOGY , no.2, pp.116-122, 2011 (SCI-Expanded, Scopus) Sustainable Development

63. Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: Effect of work environment and protective equipment

Gulten T., Evke E., ERCAN İ., EVRENSEL T., Kurt E., Manavoglu O.

WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION , vol.39, no.4, pp.485-489, 2011 (SSCI) Sustainable Development

64. Lokal İleri Mesane Kanserinde Adjuvan Kemoterapi: 32 Ol-gunun Retrospektif Analizi

ÇUBUKÇU E., CANHOROZ M., ÖLMEZ Ö. F., AVCI N., ÇUBUKÇU S., akçalı ü., et al.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , 2011 (Peer-Reviewed Journal) Sustainable Development

65. Subcutaneous Venous Port Implantation Under Guidance of Imaging Methods: Single Centre Experience

Dogan N., İNECİKLİ M. F., Ellergezen S., EVRENSEL T., Erdogan C.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.3, pp.148-155, 2010 (SCI-Expanded)

66. Capecitabine-induced cardiotoxicity mimicking myocardial infarction.

ŞENTÜRK T., Kanat O., Evrensel T., Aydinlar A.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation , vol.17, pp.277-80, 2009 (SCI-Expanded) Sustainable Development

67. Fas and Fas Ligand Expression and Relationship with Clinicopathologic Parameters in Pancreas Cancer

Goenuellue G., Ozturk H., Evrensel T., Manavoglu O.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.3, pp.584-588, 2009 (SCI-Expanded) Sustainable Development

68. Evaluation of prognostic factors on survival in non-small-cell lung cancer patients treated with postoperative radiotherapy

Sarıhan S., Gebitekin C., Bayram A. S., Ercan İ., Evrensel T., Akyıldız E. Ü.

TURK ONKOLOJI DERGISI , vol.24, no.2, pp.53-64, 2009 (ESCI)

69. Expression of cyclooxygenase-2 in ovarian serous carcinoma: correlation with angiogenesis, nm23 expression and survival.

Ozuysal S., Bilgin T., Ozgur T., Celik N., Evrensel T.

European journal of gynaecological oncology , vol.30, no.6, pp.640-5, 2009 (SCI-Expanded)

70. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer

Evrensel T., Johnson R., Ahrendt G., Bonaventura M., Falk J. S., Keenan D., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.62, no.9, pp.1379-1382, 2008 (SCI-Expanded) Sustainable Development

71. POSTOPERATIVE NODAL IRRADIATION IN MALIGNANT MELANOMA PATIENTS

Yilmaz E., Sarihan S., Kahveci R., Evrensel T., Saricaoglu H., Yerci O.

RADIOTHERAPY AND ONCOLOGY , vol.88, 2008 (SCI-Expanded)

72. RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME PATIENTS: A PROSPECTIVE STUDY

Sarihan S., Yildirim S., Ozturk H., Evrensel T., Kocaeli H., Tolunay S.

RADIOTHERAPY AND ONCOLOGY , vol.88, 2008 (SCI-Expanded)

73. The evaluation of the protective effect of venlafaxine against chemotherapy induced neuropathy

Batmazoglu M., Evrensel T., Manavoglu O., Kanat O., SIĞIRLI D.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.28, no.4, pp.425-436, 2008 (SCI-Expanded) Sustainable Development

74. Confidence intervals for proportions - the cinderella of statistical analyses - Response

Kanat O., Yalcinkaya U., Akbunar T., Kurt E., Evrensel T., Manavoglu O.

CLINICAL ONCOLOGY , vol.20, no.1, pp.93-96, 2008 (SCI-Expanded)

75. Unresectable Locally Advanced Pancreatic Cancer: Concurrent Chemotherapy

KURT M., KURT M., EVRENSEL T., Ozkan L., Manavoglu O.

METHODS OF CANCER DIAGNOSIS, THERAPY, AND PROGNOSIS , pp.227-236, 2008 (SCI-Expanded) Sustainable Development

76. Association of breast cancer and cytokine gene polymorphism in Turkish women

Gonullu G., Basturk B., Evrensel T., Oral B., Gozkaman A., Manavoglu O.

SAUDI MEDICAL JOURNAL , vol.28, no.11, pp.1728-1733, 2007 (SCI-Expanded) Sustainable Development

77. Life-threatening complications of an extremely rare tumor of the kidney: Adult-type primary renal ganglioneuroblastoma

Kurt E., Filiz G., Vuruskan H., Kurt M., Evrensel T.

SOUTHERN MEDICAL JOURNAL , vol.100, no.8, pp.852-853, 2007 (SCI-Expanded)

78. Placement technique and the early complications of balloon breast brachytherapy - Magee-Womens Hospital experience

Soran A., Evrensel T., Beriwal S., Mogus R., Keenan D., Kelley J. L., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.30, no.2, pp.152-155, 2007 (SCI-Expanded)

79. Fatal ischemic bowel necrosis possibly due to docetaxel and cisplatin in a patient with non-small cell lung cancer

Kanat O., Evrensel T., Kurt E., Keskin K., Akcali U., Manavoglu O.

LUNG CANCER , vol.56, no.1, pp.143-144, 2007 (SCI-Expanded) Sustainable Development

80. Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone

Kanat O., Baskan B. E., Kurt E., Evrensel T.

JOURNAL OF POSTGRADUATE MEDICINE , vol.53, no.2, pp.146, 2007 (SCI-Expanded)

81. Use of the breast cancer nomogram to predict non-sentinel nodal positivity in patients having received pre-operative chemotherapy

Soran A., Evrensel T., Ahrendt G., Kocer B., Johnson R.

ANNALS OF SURGICAL ONCOLOGY , vol.14, no.1, pp.165, 2007 (SCI-Expanded) Sustainable Development

82. Pleuropulmonary blastoma in an adult patient report of a case

Güzin G., EVRENSEL T., KURT E., BALABAN ADIM Ş., BAYRAM A. S., YILMAZBAYHAN E. D., et al.

Turkish Journal of Cancer , vol.37, 2007 (Peer-Reviewed Journal)

83. Efficacy of lower dose capecitabine in patients with metastatic breast cancer and factors influencing therapeutic response and outcome

Sezgin C., Kurt E., Evrensel T., Ozdemir N., Manavoglu O., Goker E.

SOUTHERN MEDICAL JOURNAL , vol.100, no.1, pp.27-32, 2007 (SCI-Expanded) Sustainable Development

84. Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer

Kurt E., Kurt M., Kanat O., Cetintas S., Aygun S., Palazoglu J., et al.

TUMORI , vol.92, no.6, pp.481-486, 2006 (SCI-Expanded) Sustainable Development

85. Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: A prospective pilot study

Demiray M., Ulukaya E., Arslan M., Gokgoz S., Saraydaroglu O., Ercan İ., et al.

CANCER INVESTIGATION , vol.24, no.7, pp.669-676, 2006 (SCI-Expanded) Sustainable Development

86. Evaluation of lung cancer metastases to the spine

Ufuk A., Öztürk Ç., Bayram A. S., Sarıhan S., Evrensel T., Halil Sedat Y.

Acta Orthopaedica Belgica , vol.72, no.5, 2006 (SCI-Expanded)

87. Comparison of uroprotective efficacy ofArticlemesna and amifostine in Cyclophosphamide- induced hemorrhagic cystitis in rats

KANAT Ö., KURT E., YALÇINKAYA Ü., EVRENSEL T., MANAVOĞLU O.

INDIAN JOURNAL OF CANCER , vol.43, no.1, pp.12-15, 2006 (Scopus)

88. The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report

Demiray M., EVRENSEL T., Kanat Ö., Kurt E., ARSLAN M., SARAYDAROĞLU Ö., et al.

Turkish Journal of Cancer , vol.35, no.1, pp.19-25, 2005 (Scopus)

89. Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients

Demiray M., EVRENSEL T., ARSLAN M., Kanat Ö., Kurt E., SARAYDAROĞLU Ö., et al.

Turkish Journal of Cancer , vol.35, no.4, pp.159-165, 2005 (Scopus)

90. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: A clinical study of 19 cases

Ozkalemkas F., Ali R., Ozkocaman V., Ozcelik T., Ozan U., Ozturk H., et al.

BMC CANCER , vol.5, 2005 (SCI-Expanded)

91. Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer

Gonullu G., Ersoy C., Ersoy A., Evrensel T., Basturk B., Kurt E., et al.

CYTOKINE , vol.31, no.4, pp.264-269, 2005 (SCI-Expanded) Sustainable Development

92. Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma

Kurt E., Sezgin C., Evrensel T., Yalcinkaya U., Kanat O., Veral A., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.59, no.5, pp.537-543, 2005 (SCI-Expanded)

93. Successful treatment of thymoma-associated erythroid hypoplasia and thrombocytopenia with paclitaxel

Kanat O., Evrensel T., Kurt E., Arslan M., Demiray M., Aker S., et al.

CLINICAL ONCOLOGY , vol.17, no.1, pp.68, 2005 (SCI-Expanded)

94. Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure

Demiray M., Kurt E., Evrensel T., Kanat O., Arslan M., Saraydaroglu O., et al.

CANCER INVESTIGATION , vol.23, no.5, pp.386-391, 2005 (SCI-Expanded) Sustainable Development

95. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients

Arslan M., Evrensel T., Kurt E., Demiray M., Ercan İ., Kanat O., et al.

NEOPLASMA , vol.52, no.1, pp.43-45, 2005 (SCI-Expanded)

96. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: A prospective six-month follow-up study

Demiray M., Gulten M., Manavoglu O., Evrensel T., Ulukaya E., Yerci O., et al.

HEPATO-GASTROENTEROLOGY , vol.51, no.59, pp.1531-1535, 2004 (SCI-Expanded)

97. Comparison of clinical outcomes of different erythropoietin usage strategies

Arslan M., Evrensel A., Kurt E., Demiray M., Gonullu G., Kanat O., et al.

TUMORI JOURNAL , vol.90, no.4, pp.394-398, 2004 (SCI-Expanded)

98. Treatment of metastatic pancreatic cancer with a combination of gemcitabine and 5-fluorouracil: A single center phase II study

Kanat O., Evrensel T., Kurt E., Demiray M., Gonullu G., Arslan M., et al.

TUMORI , vol.90, no.2, pp.192-195, 2004 (SCI-Expanded) Sustainable Development

99. Amifostine is as effective as Mesna against cyclophosphamide-induced hemorrhagic cystitis in rats

Kanat O., Kurt E., YALÇINKAYA Ü., EVRENSEL T., Aker S., Manavoglu O.

ANNALS OF ONCOLOGY , vol.15, pp.227, 2004 (SCI-Expanded)

100. **Prognostic value of nm23 in gastrointestinal stromal tumors**

Kanat O., Adim Ş., Evrensel T., Yerci O., Ediz B., Kurt E., et al.

MEDICAL ONCOLOGY , no.1, pp.53-57, 2004 (SCI-Expanded)

101. Systemic AA amyloidosis and nephrotic syndrome associated with small cell carcinoma of the bladder

Kanat O., Evrensel T., Filiz G., Usta M., Baskan E., Dilek K., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.18, no.11, pp.2453-2454, 2003 (SCI-Expanded)

102. Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older

Kanat O., Evrensel T., Demiray M., Kurt E., Gonullu G., Arslan M., et al.

LUNG CANCER , vol.41, no.2, pp.233-234, 2003 (SCI-Expanded) Sustainable Development

103. Single-agent irinotecan as second-line treatment for advanced gastric cancer

Kanat O., Evrensel T., Manavoglu O., Demiray M., Kurt E., Gonullu G., et al.

TUMORI JOURNAL , vol.89, no.4, pp.405-407, 2003 (SCI-Expanded) Sustainable Development

104. Small cell carcinoma of the urinary bladder. A clinicopathologic study of five cases

Kanat O., Evrensel T., Adim Ş., Yavascaoglu I., Kurt E., Demiray M., et al.

TUMORI JOURNAL , no.3, pp.328-330, 2003 (SCI-Expanded)

105. Tc-99m-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy

Alper E., Gurel M., Evrensel T., Ozkocaman V., Akbunar T., Demiray M.

NUCLEAR MEDICINE COMMUNICATIONS , vol.24, no.5, pp.537-542, 2003 (SCI-Expanded)

106. Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer - A single center randomized study

Kanat O., Evrensel T., Baran I., Coskun H., Zarifoglu M., Turan O., et al.

MEDICAL ONCOLOGY , vol.20, no.3, pp.237-245, 2003 (SCI-Expanded) Sustainable Development

107. A case of primary spinal intramedullary lymphoma

Bekar A., Cordan T., Evrensel T., Tolunay S.

SURGICAL NEUROLOGY , vol.55, no.5, pp.261-264, 2001 (SCI-Expanded)

108. Primary neuroendocrine small cell carcinoma of the breast

Samli B., Celik S., Evrensel T., Orhan B., Tasdelen I.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE , vol.124, no.2, pp.296-298, 2000 (SCI-Expanded)

109. The significance of fine needle aspiration biopsy in diagnosis of pancreatic lesions Pankreas lezyonlarinin tanisinda ince igne aspirasyon biyopsisinin yeri

YERCİ Ö., GÜREL S., Ozturk H., Dolar E., BALABAN S., ORHAN B., et al.

Turkish Journal of Gastroenterology , vol.10, no.4, pp.367-371, 1999 (SCI-Expanded) Sustainable Development

110. Effect of cisplatin on plasma renin activity and serum aldosterone levels

Kurt E., Manavoglu O., Dilek K., Orhan B., Evrensel T.

CLINICAL NEPHROLOGY , vol.52, no.6, pp.397-398, 1999 (SCI-Expanded)

111. Cervical spine involvement in metastatic colorectal carcinomas: Should we think about an alternative route of metastasis other than Batson's plexus?

Orhan B., Manavoglu O., Evrensel T., Kurt E.

CLINICAL ONCOLOGY , vol.11, no.1, pp.65, 1999 (SCI-Expanded)

112. Does cisplatin stimulate erythropoietin secretion from the peritubular cells of the kidney?

Orhan B., Yalcin S., Evrensel T., Kurt E., Manavoglu O., Erbas T.

CLINICAL NEPHROLOGY , vol.50, no.3, pp.202-203, 1998 (SCI-Expanded)

113. Successful treatment of cranial metastases of extrapulmonary small cell carcinoma with chemotherapy alone

Orhan B., Yalcin S., Evrensel T., Yerci O., Manavoglu O.

MEDICAL ONCOLOGY , vol.15, no.1, pp.66-69, 1998 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 75

1. Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program (EAP).

Tural D., Ozkan O., YASLIKAYA Ş., TATLI A. M., Akdag G., Demir H., et al.

American-Society-of-Clinical-Oncology: Genitourinary Cancers Symposium, San-Francisco, Costa Rica, 13 - 15 February 2025, (Summary Text)

2. Metastatik Kolorektal Kanserde Dolaşımdaki Tümör Hücresi Durumu ile İlişkili miRNA Profillerinin Belirlenmesi

Doğan B., Pirim D., Bağcı F. A., Işık Ö., Evrensel T.

IX. Multidisipliner Kanser Araştırma Kongresi, Tunceli, Turkey, 2 - 03 May 2024, (Summary Text) Sustainable Development

3. Kemoterapi Sırasında Kanser Hastalarına Dinletilen İki Farklı Türde Müziğin Anksiyete, Bulantı ve Memnuniyet Düzeylerine Etkisi

Erbay Dallı Ö., Akça Doğan D., Pehlivan S., Yıldırım Y., Evrensel T.

20. Uludağ İç Hastalıkları Ulusal Kış Kongresi, 14. Uludağ İç Hastalıkları Hemşireliği Kongresi, Bursa, Turkey, 2 - 04 March 2024, pp.121, (Summary Text) Sustainable Development

4. Assessing HSP70 and TCP1 Status of Circulating Tumor Cells in MetastaticColorectal Cancer

Pirim D., Dogan B., Bağcı F. A., Işik Ö., Evrensel T.

IX. International Molecular Medicine, 18 - 20 December 2023, pp.10, (Summary Text)

5. The Effects of Ankaferd Hemostat on Preventing Oral Mucositis in Colorectal Cancer Patients Receiving Chemotherapy

KARACAN Y., YILDIZ H., EVRENSEL T., HAZNEDAROĞLU İ. C.

ONKOLOJİ HEMŞİRELİĞİ KONGRESİ, Ankara, Turkey, 22 November 2023, (Summary Text)

6. Evaluation of Circulating Tumor Cell (CTC) Specific Markers and CTC Status in Metastatic Colorectal Cancer Patients by Immunomagnetic Cell-Selection Method

DOĞAN B., PİRİM D., IŞIK Ö., EVRENSEL T.

3rd International Multidisciplinary Cancer Research Congress, İstanbul, Turkey, 07 September 2023, pp.95-96, (Summary Text)

7. Evaluation of Immunotherapy Treatment Approaches in Organotypic Models

AKGÜN O., YILDIZ Y., ERTÜRK E., YÖYEN ERMİŞ D., DOMBAZ F., ORAL H. B., et al.

Uluslararası katılımlı 26. Ulusal Elektron Mikroskopi Kongresi, Eskişehir, Turkey, 20 - 23 September 2023, pp.222, (Summary Text)

8. Assessing HSP70 and TCP1 status of circulating tumor cells in metastatic colorectal cancer patients

Pirim D., Doğan B., Bağcı F. A., Işık Ö., Evrensel T.

IX. International Congress of Molecular Medicine, İstanbul, Turkey, 18 - 20 December 2023, (Summary Text) Sustainable Development

9. Glioblastoma multiforme tanılı olgularımızda sağkalım ve prognostik faktörler

Aslan G. G., Abanoz İ., Evrensel T., Kocaeli H., Sarıhan S.

14. Ulusal Radyasyon Onkolojisi Kongresi, 26-30 Kasım 2021, Antalya, Türkiye, Bildiri özetleri kitabı, PS-165, S: 157-158, Antalya, Turkey, 26 - 30 November 2021, pp.157-158, (Summary Text)

10. KANSER HASTALARININ ORAL KEMOTERAPİ İLAÇLARINA UYUMUNUN DEĞERLENDİRİLMESİ

Akaltun N., YILDIZ H., Tekeli F., Macun S., OCAK B., ÇUBUKÇU E., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text)

11. HASTA VE HASTA YAKINLARININ HEMŞİRELİK HİZMETİNDEN MEMNUNİYETLERİNİN DEĞERLENDİRİLMESİ, MEMNUNİYET DÜZEYLERİ AYNI MI?

Akaltun N., Ay S., YILDIZ H., ÇUBUKÇU E., EVRENSEL T.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text)

12. The prognostic factors affecting recurrence free survival in metaplastic and triple negative tumors.

ŞENOL K., Ceferli O., POLATKAN S. A. V., ŞAHİN A. B., DELİGÖNÜL A., ÖZŞEN M., et al.

International Breast Cancer Symposium, İzmir, Turkey, 08 October 2021, (Full Text)

13. Prognostic Biomarkers in Lung Cancer Patients in terms of Long-term Survival

COŞKUN B. N., DİZDAR O. S., KORKMAZ Ş., ULUKAYA E., EVRENSEL T.

17. Uludağ İç Hastalıkları Kış Kongresi, 05 March 2021, (Full Text) Sustainable Development

14. Metastatik Küçük Hücreli Akciğer Kanserinde Tek Merkez Atezolizumab Deneyimi

Şahin A. B., Ocak B., Çubukçu E., Evrensel T.

Ulusal Akciğer Sağlığı Kongresi 2020, Antalya, Turkey, 11 - 15 March 2020, (Summary Text) Sustainable Development

15. Primary surgery in patients with de novo stage IV BC; finalizing the protocol MF07-01 randomized clinical trial

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 10 - 14 December 2019, vol.80, (Summary Text)

16. Metastatik Prostat Kanserinde Tek Merkez Postdosetaksel Kabazitaksel Deneyimi

Caner B., Şahin A. B., Ocak B., Orhan Oyucu S., Öztop H., Deligönül A., et al.

8. Onkolojide Arayışlar Sempozyumu, İzmir, Turkey, 13 - 15 December 2019, pp.47, (Summary Text)

17. KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİ(ADENOKARSİNOM) GASTROİNTESTİNAL SİSTEM MULTİPL METASTAZI: OLGU SUNUMU

DELİGÖNÜL A., ŞAHİN A. B., ÇUBUKÇU E., UĞRAŞ N., EVRENSEL T.

KANSERDE GÜNCEL GELİŞMELER 2019 AKCİĞER KANSERİ SEMPOZYUMU, Diyarbakır, Turkey, 22 November 2019, (Summary Text)

18. Comparisıon of the 7th and 8th edition of tnm stagıng for nsclc ın patıents undergoıng pılmonary resectıon after neoadjuvant ınductıon treatment

Sevinç T., Çetinkaya G., Bayram A. S., Deligönül A., Çubukçu E., Evrensel T., et al.

2019 world conference on lung cancer, september 2019, Barcelona, Spain, 7 - 10 November 2019, vol.14, no.103, pp.548, (Summary Text)

19. Finding a place for pathological near complete response patıents following neoadjuvant /ınduction therapy in the tnm staging

çetinkaya g., sevinç T., DELİGÖNÜL A., ÖZER E., ÇUBUKÇU E., BAYRAM A. S., et al.

2019 world conference on lung cancer, september 2019, 7 - 10 November 2019

20. 65 YAŞ ÜZERİ LOKAL İLERİ REKTUM KANSERİ TEDAVİSİ: TEK MERKEZ DENEYİMİ

CANER B., ŞAHİN A. B., OCAK B., OYUCU ORHAN S., KAĞIZMANLI H., DELİGÖNÜL A., et al.

3.GERİATRİK ONKOLOJİ SEMPOZYUMU, İzmir, Turkey, 09 November 2019, (Summary Text) Sustainable Development

21. 65 Yaş Üzeri Lokal İleri Rektum Kanseri Tedavisi Tek Merkez Deneyimi

Caner B., Şahin A. B., Ocak B., Orhan Oyucu S., Kağızmanlı H., Deligönül A., et al.

3. Geriatrik Onkoloji Sempozyumu, İzmir, Turkey, 09 November 2019, (Summary Text)

22. Metastatik Prostat Kanserinde Tek Merkez Post Docetaksel Abirateron Deneyimi

Şahin A. B., Ocak B., Caner B., Orhan Oyucu S., Öztop H., Deligönül A., et al.

3.ULUSAL ÜROGENİTAL KANSERLER KONGRESİ, Girne, Cyprus (Kktc), 24 - 27 October 2019, (Full Text)

23. METASTATİK PROSTAT KANSERİNDE TEK MERKEZ POST-DOSETAXEL ABİRATERON DENEYİMİ

ŞAHİN A. B., OCAK B., CANER B., OYUCU ORHAN S., ÖZTOP H., DELİGÖNÜL A., et al.

3. ULUSAL ÜROGENİTAL KANSERLER KONGRESİ, Girne, Cyprus (Kktc), 24 October 2019, (Summary Text)

24. GASTROİNTESTİNAL STROMAL TÜMÖR TANISI OLAN HASTALARIN DEMOGRAFİK VE KLİNİK ÖZELLİKLERİNİN RETROSPEKTİF DEĞERLENDİRİLMESİ

YÜCEL ÇAMCI N., DELİGÖNÜL A., ÇUBUKÇU E., EVRENSEL T.

3. MUĞLA MULTİDİSİPLİNER ONKOLOJİK ARAŞTIRMALAR KONGRESİ, Muğla, Turkey, 18 October 2019, (Summary Text)

25. The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial

Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., Canturk Z., et al.

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, (Summary Text)

26. S 05: AKCİĞER KANSERLİ YAŞLI HASTADA İMMUNOTERAPİ:VAKA SUNUMU

ŞAHİN A. B., OCAK B., DELİGÖNÜL A., EVRENSEL T.

6. KARADENİZ ONKOLOJİ KONGRESİ, Trabzon, Turkey, 19 September 2019, (Summary Text)

27. Comparison of the 7th and 8th edition of TNM staging for NSCLC in patients undergoing pulmonary resection after neoadjuvant/Induction treatment

Melek H., Sevinç T., Çetinkaya G., Bayram A. S., Deligönül A., Çubukçu E., et al.

IASLC 2019 World Conference on Lung cancer, September 7-10, 2019, Barcelona, Spain, P1.13-07, S548, Barcelona, Spain, 7 - 10 September 2019, pp.548, (Summary Text)

28. The role of loco-regional treatment in long-term quality of life in de novo Stage IV breast cancer patients: Protocol MF07-01Q

Soran A., Soyder A., Ozbas S., ÖZMEN V., Karanlik H., Igci A., et al.

20th Annual Meeting of the American-Society-of-Breast-Surgeons, Texas, United States Of America, 30 April - 05 May 2019, vol.26, pp.37-38, (Summary Text) Sustainable Development

29. ETS sonrası kompanzatuar hiperhidrozis tedavisinde interkostal sinir rekonstrüksiyonu

MELEK H., çetinkaya g., sevinç T., DELİGÖNÜL A., ÖZER E., ÇUBUKÇU E., et al.

10. ulusal göğüs cerrahisi kongresi, Turkey, 25 - 29 April 2019

30. Mültidisipliner Olgu Tartışması

TOLUNAY Ş., GÖKGÖZ M. Ş., EVRENSEL T., ARIBAL M. E., GÖKALP G., ÇETİNTAŞ S.

10.Ercan Tuncel Radyoloji Günleri, Bursa, Turkey, 6 - 07 April 2019, (Full Text)

31. Meme Kanserinde İnteraktif Olgu Sunumları

GÖKGÖZ M. Ş., TOLUNAY Ş., SOYDER A., EVRENSEL T., ÇETİNTAŞ S., GÖKALP G., et al.

8.Uludağ Genel Cerrahide Güncel Yaklaşımlar Toplantısı, Turkey, 15 - 17 March 2019, (Full Text) Sustainable Development

32. Kemoterapi Alan Hastaların Hemşirelik Bakımını Algılayışının Değerlendirilmesi

Akaltun N., Ay S., YILDIZ H., EVRENSEL T.

20.Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 10 - 14 October 2018, (Summary Text)

33. Meme Kanserlerinde Lokorejyonel nüks oranlarımız

ÇETİNTAŞ S., Paksoy E., EVRENSEL T., YALÇINKAYA Ü., Taşdelen i., GÖKGÖZ M. Ş.

Türk Cerrahi Derneği, Ulusal Cerrahi Kongresi, Turkey, 11 - 15 April 2018, (Full Text) Sustainable Development

34. DPYD IVS141GA Variantı Olan İleri Evre Kolorektal Kanser Hastalarında 5-FU’ya Bağlı Hematolojik Yan Etkiler

DELİGÖNÜL A., KANAT Ö., AK S., TEZCAN G., EVRENSEL T., TUNCA B., et al.

14. Uludağ İç Hastalıkları Kış Kongresi, 3. Bursa Aile Hekimliği Derneği Ulusal Kongresi, Turkey, 4 March - 07 April 2018 Sustainable Development

35. Kolorektal Kanserli Hastalarda Mikrostallit İnstabilite Ve Klinik Önemi

DELİGÖNÜL A., AVCI N., ÇUBUKÇU E., HAFIZOĞLU M., hafızoğlu e., EVRENSEL T.

14. ULUDAĞ İÇ HASTALIKLARI, Turkey, 28 March 2018, (Summary Text) Sustainable Development

36. DPYD IVS141GA Variantı Olan İleri Evre Kolorektal Kanser Hastalarında 5-FU’xxya Bağlı Hematolojik Yan Etkiler

DELİGÖNÜL A., KANAT Ö., AKSOY S., TEZCAN G., EVRENSEL T., TUNCA B., et al.

14. İÇ HASTALIKLARI KIŞ KONGRESİ, 3. BURSA AİLE HEKİMLİĞİ KONGRESİ, 8. ULUDAĞ HEMŞİREKİL KONGRESİ, Bursa, Turkey, 4 - 07 March 2018, (Summary Text) Sustainable Development

37. Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Yalcin S., Dane F., Oksuzoglu B., Yildirim N., Isikdogan A., Ozkan M., et al.

Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica, 18 - 20 January 2018, vol.36, (Summary Text) Sustainable Development

38. The importance of loco-regional tumor burden and surgery on survival in patients with de novo stage IV breast cancer; post-hoc analyses of protocol MF07-01

Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., Canturk Z., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 6 - 10 December 2016, vol.77, (Summary Text) Sustainable Development

39. Radiotherapy as Definitive Treatment in Patients Aged 70 Years and Older with Non small Cell Lung Cancer

Sarıhan S., Evrensel T., Sığırlı D.

IASLC 17TH WORLD CONFERENCE ON LUNG CANCER, Vienna, Austria, 4 - 07 December 2016, pp.542, (Summary Text)

40. Radiotherapy as definitive treatment in patients aged 70 years and older with non small cell lung cancer

SARIHAN S., EVRENSEL T., SIĞIRLI D.

IASLC 17th World Conference on Lung Cancer, December 4-7, P2.05, Vienna, Austria, 4 - 07 December 2016 Sustainable Development

41. İNDÜKSİYON TEDAVİSİ SÜRECİNDE VÜCUT KİTLE İNDEKSİ DEĞİŞİMİNİN CERRAHİ SONUÇLARA ETKİSİ

ÖZER E., ÇETİNKAYA G., DELİGÖNÜL A., MELEK H., EROL M. M., KURT E., et al.

7. ULUSAL AKCİĞER KANSERİ KONGRESİ, Antalya, Turkey, 24 November 2016, (Summary Text)

42. Cerrahi Uygulanan Lokal İleri Evre Akciğer Kanserli Hastalarda neoadjuvan Tedavi Sürecinde Vücut Kitle İndexi Degişiminin Morbidite, Mortalite, Uzun Dönem Yaşam ve Patolojik Tam Yanıt Üzerine Etkileri

ÇETİNKAYA G., DELİGÖNÜL A., MELEK H., KURT E., EROL M. M., BAYRAM A. S., et al.

TÜRK SOLUNUM ARAŞTIRMALARI DERNEĞİ 38. ULUSAL KONGRESİ, İzmir, Turkey, 15 October 2016, (Summary Text)

43. A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (Protocol MF07-01).

Soran A., ÖZMEN V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34, (Summary Text) Sustainable Development

44. Bevacizumab’ a tam yanıtlı kranial metastazlı troid insular karsinom nadir bir olgu.

DELİGÖNÜL A., AVCI N., NAS Ö. F., ÇUBUKÇU E., ÖZ GÜL Ö., EVRENSEL T.

6. Onkoloji kongresi, Turkey, 23 - 27 March 2016, (Full Text)

45. Meme Kanserli Hastalarda CYP2D6 Genotipinin Tamoxifen e Direnç Gelişimi Ve Histopatolojik Özellikler İle İlişkisi

DEMİRCİ H., ÇEÇENER G., TUNCA B., TEZCAN G., TEZCAN H., EGELİ Ü., et al.

13. Ulusal Meme Hastalıkları kongresi, Turkey, 21 - 25 October 2015 Sustainable Development

46. NEOADJUVAN TEDAVİ SONRASI AKCİĞER REZEKSİYONU UYGULANMIŞ ve HİSTOPATOLOJİK OLARAK DOWNSTAGE(T1-2N0) OLDUĞU GÖSTERİLMİŞ HASTALARDA PATOLOJİK EVRE(yp) GERÇEK EVREYİ YANSITIYORMU?

MELEK H., ÇETİNKAYA G., DELİGÖNÜL A., KURT E., EROL M. M., BAYRAM A. S., et al.

TÜRKİYE SOLUNUM ARAŞTIRMALARI DERNEĞİ 37. ULUSAL KONGRESİ, İzmir, Turkey, 17 October 2015, (Summary Text)

47. Kranial Metastazlı Akciğer Kanserli Olgularda Metastazektominin Sağ Kalıma Etkisi

Deligönül A., Taşkapılıoğlu M. Ö., Melek H., Bekar A., Çetinkaya G., Sarıhan S., et al.

TÜSAD 37. ULUSAL KONGRESİ - SOLUNUM, İzmir, Turkey, 17 - 21 October 2015, pp.49, (Summary Text)

48. Neoadjuvan Tedavi Sonrası Akciğer Rezeksiyonu Uygulanmış ve Histopatolojik Olarak Downstage t1 2n0 Olduğu Gösterilmiş Hastalarda Patolojik Evre yp Gerçek Evreyi Yansıtıyor mu

Melek H., Çetinkaya G., Deligönül A., Kurt E., Erol M. M., Bayram A. S., et al.

TÜSAD 37. ULUSAL KONGRESİ - SOLUNUM, İzmir, Turkey, 17 - 21 October 2015, pp.15, (Summary Text)

49. The survival effect of resection of cranial metestatic lesions in patients with lung cancer

Deligönül A., Taşkapılıoğlu M. Ö., Melek H., Bekar A., Çetinkaya G., Sarıhan S., et al.

IASLC 16th World Conference on Lung Cancer, September 6-9, 2015, P2.01, Colorado, United States Of America, 6 - 09 September 2015, pp.35, (Summary Text)

50. Senkron Beyin Metastazı Olan Küçük Hücreli Dışı Akciğer Kanserli Hastalarda Cerrahi Tedavi

Deligönül A., Melek H., Taşkapılıoğlu M. Ö., Çetinkaya G., Bayram A. S., Evrensel T., et al.

Toraks derneği, 18. Yıllık kongresi, 2015, Antalya, Turkey, 1 - 05 April 2015, pp.11, (Summary Text)

51. Neoadjuvan tedaviye patolojik tam yanıtın preoperatif saptanmasında petin rolü

MELEK H., ŞEN F., ÇETİNKAYA G., EROL M. M., DELİGÖNÜL A., EVRENSEL T., et al.

Ulusal akciğer kanserleri kongresi 2015, Antalya, Turkey, 12 - 15 March 2015, (Summary Text)

52. Neoadjuvan tedavi sonrası akciğer rezeksiyonu morbidite mortalite ve sağ kalım 519 hastanın analizi

Melek H., Demir A., Bayram A. S., Berker Ö., Çetinkaya G., Duman S., et al.

Ulusal akciğer kanserleri kongresi 2015, Antalya, Türkiye, 12 - 15 Mart 2015, Antalya, Turkey, 12 - 15 March 2015, (Summary Text)

53. MALİGN PLEVRAL EFÜZYON TEDAVİSİNDE KÜÇÜK ÇAPLI KATATER UYGULAMASININ ETKİNLİĞİ

DELİGÖNÜL A., MELEK H., DEMİRTAŞ C. Ö., ÇETİNKAYA G., KANAT Ö., EROL M. M., et al.

TÜRK SOLUNUM ARAŞTIRMALARI DERNEĞİ 36. ULUSAL KONGRESİ, İzmir, Turkey, 15 October 2014, (Summary Text)

54. NEOADJUVAN TEDAVİ SONRASI AKCİĞER REZEKSİYONU, MORBİDİTE VE MORTALİTE

MELEK H., ÇETİNKAYA G., EROL M. M., BAYRAM A. S., DELİGÖNÜL A., EVRENSEL T., et al.

TÜRK TORAKS DERNEĞİ 17. YILLIK KONGRESİ, Antalya, Turkey, 02 April 2014, (Summary Text)

55. The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme

Olmez O. F., Cubukcu E., Evrensel T., KURT M., Avci N., Tolunay S., et al.

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49, (Summary Text)

56. Küçük hücreli dışı akciğer karsinomlu hastalarda neoadjuvan tedavi sonrası pnömonektomi Artmış uzun süreli sağkalım Sözlü sunum

Melek H., Erol M. M., Bayram A. S., Evrensel T., Sarıhan S., Akyıldız E. Ü., et al.

7. Ulusal Göğüs Cerrahisi Kongresi, Antalya, 2013, Antalya, Turkey, 25 - 28 April 2013, pp.45, (Full Text)

57. Neoadjuvan tedavi sonrası cerrahi ile patolojik downstage olduğu tespit edilen hastalarda beklenilmeyen oldukça iyi sağkalım Sözlü sunum 1 ödülü

Gebitekin C., Toker S. A., Melek H., Erus S., Bayram A. S., Özkan B., et al.

Ulusal Akciğer Kanseri Kongresi, Kapadokya, 2013, Nevşehir, Turkey, 14 - 17 March 2013, pp.98, (Full Text)

58. Is The Measurement Of Total Cell Death, Not Solely Apoptosis, Better Indicator Of Response To Taxane-based Chemotherapy In Lung Cancer Patients?

Evrensel T., Ulukaya E., Coskun B., Korkmaz S., Olmez O., Cubukcu E., et al.

Chicago Multidisciplinary Symposium in Thoracic Oncology, Illinois, United States Of America, 6 - 08 September 2012, vol.7, (Summary Text) Sustainable Development

59. Neoadjuvant Treatment Followed by Surgery in Patients with N2 NSCLC: Is Complete response a better sign of long term survival?

Melek H., Erol M., Bayram A. S., Evrensel T., Saruhan S., Akyildiz E., et al.

Chicago Multidisciplinary Symposium in Thoracic Oncology, Illinois, United States Of America, 6 - 08 September 2012, vol.7, (Summary Text)

60. Alterations of miRNA expression in early-onset Turkish colorectal cancer patients’ tumor tissues.

AKSOY S., TUNCA B., ÇEÇENER G., EGELİ Ü., TEZCAN G., ZORLUOĞLU A., et al.

22nd Biennial Congress of the European Association for Cancer Research, 2012, Barselona, Spain, 7 - 10 July 2012, vol.48, (Summary Text) Sustainable Development

61. Alterations of MiRNA Expression in Early-onset Turkish Colorectal Cancer Patients' Tumor Tissues

Ak S., Tunca B., Cecener G., Egeli Ü., Tezcan G., Zorluoglu A., et al.

22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, Spain, 7 - 10 July 2012, vol.48, (Summary Text) Sustainable Development

62. Timomalarda küratif cerrahinin önemi Sözlü sunum

Erol M. M., Melek H., Bayram A. S., Akyıldız E. Ü., Sarıhan S., Evrensel T., et al.

Türk Toraks derneği, 15. Yıllık Kongresi, Antalya, 2012, Antalya, Turkey, 11 - 15 April 2012, pp.159, (Full Text)

63. 70 yaş üstü küçük hücreli dışı akciğer kanserli hastalarda küratif radyoterapi (sözlü sunum)

Sarıhan S., Okumuş D., Kekilli E., Evrensel T., Sığırlı D., Özkan L.

V. Ulusal Akciğer Kanseri Kongresi, 23-26 Şubat 2012 İstanbul, İstanbul, Turkey, 23 - 26 February 2012, pp.7, (Full Text)

64. Thymoma ve Thymic Karsinomlu Hastalarda Moleküler Belirteçlerin Değerlendirilmesi

ÇEÇENER G., AVCI N., TUNCA B., EGELİ Ü., EVRENSEL T., BAYRAM A. S., et al.

XII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 27 - 30 October 2011, (Summary Text)

65. What is the predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy (NCT) for locally advanced breast cancer?

Soran A., Evrensel T., Ahrendt G., Kocer B., Bonaventura M., Falk J., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.98, (Summary Text) Sustainable Development

66. Placement technique and the early complications of partial breast irradiation; Magee-Womens Hospital experience.

Soran A., Johnson R., Beriwal S., Mogus R., Evrensel T., Bonaventura M., et al.

29th Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 14 - 17 December 2006, vol.100, (Summary Text)

67. Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)

Ozguroglu M., Evrensel T., Er O., TURNA Z. H., Yanmaz T., Yildiz O., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.225, (Summary Text) Sustainable Development